Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
McKinsey
Mallinckrodt
Moodys
Boehringer Ingelheim

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ornidazole

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Ornidazole: Sponsors, patents, clinical trial progress

Ornidazole is an investigational drug.

There have been 7 clinical trials for Ornidazole. The most recent clinical trial was a Phase 2 trial, which was initiated on March 3rd 2018.

The most common disease conditions in clinical trials are Recurrence, Crohn Disease, and Colonic Neoplasms. The leading clinical trial sponsors are Assistance Publique - Hôpitaux de Paris, Haining Health-Coming Biotech Co., Ltd., and University Hospital, Clermont-Ferrand.

There are four hundred and twelve US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Ornidazole
TitleSponsorPhase
Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer SurgeryAssistance Publique - Hôpitaux de ParisPhase 3
Mechanical Bowel Preparation and Oral Antibiotics Before Rectal Cancer SurgeryAssistance Publique - Hôpitaux de ParisPhase 3
Metronidazole as an Adjunct of Non- Surgical Treatment of Peri-implantitisOsteology FoundationPhase 4

See all Ornidazole clinical trials

Clinical Trial Summary for Ornidazole

Top disease conditions for Ornidazole
Top clinical trial sponsors for Ornidazole

See all Ornidazole clinical trials

US Patents for Ornidazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ornidazole   See Pricing Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof The Regents of the University of California (Oakland, CA)   See Pricing
Ornidazole   See Pricing Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)   See Pricing
Ornidazole   See Pricing Drug device configured for wireless communication Pop Test Abuse Deterrent Technology, LLC (Cliffside Park, NJ)   See Pricing
Ornidazole   See Pricing Treatments for gastrointestinal conditions Board of Regents, The University of Texas System (Austin, TX) St. Jude Children's Research Hospital, Inc. (Memphis, TN)   See Pricing
Ornidazole   See Pricing Boron-containing small molecules as antiprotozoal1 agents MMV MEDICINES FOR MALARIA VENTURE (Geneva, CH)   See Pricing
Ornidazole   See Pricing Cadotril particles Johnson & Johnson Consumer Inc. (Skillman, NJ)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ornidazole

Drugname Country Document Number Estimated Expiration Related US Patent
Ornidazole European Patent Office 2981556 2033-04-02   See Pricing
Ornidazole World Intellectual Property Organization (WIPO) 2014165513 2033-04-02   See Pricing
Ornidazole World Intellectual Property Organization (WIPO) 2014052836 2032-09-27   See Pricing
Ornidazole European Patent Office 3151906 2034-06-03   See Pricing
Ornidazole World Intellectual Property Organization (WIPO) 2015187289 2034-06-03   See Pricing
Ornidazole European Patent Office 3116499 2034-03-12   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Johnson and Johnson
Moodys
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.